Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's revision tag changed from v3.6.6 to v3.7.0, indicating a new build of the site interface. This change does not modify the study record details or data.SummaryDifference0.0%

- Check21 days agoChange DetectedThe Record History page appears with a redesigned header and list formatting, while the underlying history data and navigation remain unchanged.SummaryDifference0.0%

- Check29 days agoChange DetectedNo additions or deletions are present in the change history data. The page content remains unchanged from the previous version.SummaryDifference0.0%

- Check36 days agoChange DetectedThe history shows a new site revision from v3.6.5 to v3.6.6. This indicates a deployment with minor fixes or improvements that do not change study information.SummaryDifference0.0%

- Check57 days agoChange DetectedA new revision entry, v3.6.5, is added to the record history, replacing the previous v3.6.4. This indicates a software release update to the page rather than changes to trial data or content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe footer revision label updated from v3.6.3 to v3.6.4. This reflects a new build of the ClinicalTrials.gov interface.SummaryDifference0.0%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.